MARLBOROUGH, Mass.--(BUSINESS WIRE)--Boston Biomedical Associates (BBA) will be one of the lead presenters and sponsors at the annual Outsourcing in Clinical Trials Israel conference in Tel Aviv March 21-22, 2017. This conference is the only clinical outsourcing platform in the Middle East for the medical device and biopharma industry. It provides attendees with the exclusive opportunity to discuss how they can develop their outsourcing strategies and improve operational efficiency in clinical trials to remain cost- and time-effective.
Tami Abudi, the Co-CEO and Clinical Director of BBA Ltd. Israel, will present a program entitled “Outlining Global Considerations in First-In-Human (FIH) Clinical Trials.”
“Boston Biomedical Associates is highly regarded in the United States and Israel for the comprehensive experience and services we offer clients who are working with global regulatory authorities to obtain approval for new therapies,” Abudi said. “This conference is an excellent opportunity for us to share our experience and ideas on clinical outsourcing with other thought leaders in Israel,” she added.
Boston Biomedical Associates
BBA serves as a strategic partner with clients involved in a variety of medical technologies and working with them throughout the entire medical product life cycle to facilitate bringing new products to market. BBA is also a leading Clinical Research Organization known for its comprehensive approach to facilitating the clinical trial operations process.
For more information on 2017 Outsourcing in Clinical Trials Israel: http://www.arena-international.com/octisrael. For more information on Boston Biomedical Associates: http://www.boston-biomedical.com or contact Mack Rubley, PhD, BBA’s Director of Business Development: firstname.lastname@example.org or 508-691-7041.